Stimulation of human monocytic THP-1 cells by metabolic activation of hepatotoxic drugs.

Drug-induced liver injury (DILI) is thought to be involved in the participation of drugs that either directly affect the cell viability or elicit an immune response. However, there is limited information about the immune responses induced by drugs, including those drugs that are metabolically activated. In this study, we constructed an in vitro assay system to assess the involvement of immune-related factors induced by metabolic activation of drugs. To investigate whether CYP3A4-mediated metabolism of 10 hepatotoxic drugs is associated with immune-related responses, human monocytic leukemia THP-1 cells were co-incubated with CYP3A4 Supersomes. Cluster of differentiation (CD) 86 and CD54 expression levels on THP-1 cells were upregulated by treatment with albendazole and amiodarone (AMD), respectively, in the presence of CYP3A4. Additionally, N-desethylamiodarone (DEA), a major metabolite of AMD, upregulated the CD54 expression of THP-1 cells with CYP3A4. The release of interleukin (IL)-8 and tumor necrosis factor (TNF) α from THP-1 cells was significantly increased by the treatment of AMD or DEA with CYP3A4. Similarly, IL-8 and TNFα were also upregulated by the treatment of AMD and DEA with human liver microsomes, but were inhibited by adding ketoconazole to the cell culture. In this study, we first report that albendazole, AMD and DEA activate immune reaction when metabolically activated.

[1]  T. Fukami,et al.  Terbinafine stimulates the pro-inflammatory responses in human monocytic THP-1 cells through an ERK signaling pathway. , 2010, Life sciences.

[2]  S. Krähenbühl,et al.  The role of CYP3A4 in amiodarone-associated toxicity on HepG2 cells. , 2011, Biochemical pharmacology.

[3]  H. Breuer,et al.  Amiodarone-induced severe hepatitis mediated by immunological mechanisms. , 1998, International journal of clinical pharmacology and therapeutics.

[4]  T. Fukami,et al.  Stimulation of pro-inflammatory responses by mebendazole in human monocytic THP-1 cells through an ERK signaling pathway , 2011, Archives of Toxicology.

[5]  H. Sakaguchi,et al.  Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[6]  M. Ingelman-Sundberg,et al.  Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model. , 2009, Toxicology in vitro : an international journal published in association with BIBRA.

[7]  K. Tsuneyama,et al.  Halothane-induced liver injury is mediated by interleukin-17 in mice. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  Christopher J Sinal,et al.  Disruption of Hepatic Lipid Homeostasis in Mice after Amiodarone Treatment Is Associated with Peroxisome Proliferator-Activated Receptor-αTarget Gene Activation , 2004, Journal of Pharmacology and Experimental Therapeutics.

[9]  B. Dewald,et al.  Interleukin-8 and related chemotactic cytokines--CXC and CC chemokines. , 1994, Advances in immunology.

[10]  G. Kolde,et al.  An in vitro test for endocytotic activation of murine epidermal Langerhans cells under the influence of contact allergens. , 1994, Journal of immunological methods.

[11]  H. Yamazaki,et al.  Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions. , 2000, British journal of clinical pharmacology.

[12]  K. Tsuneyama,et al.  IL-4 mediates dicloxacillin-induced liver injury in mice. , 2011, Toxicology letters.

[13]  F. Guengerich,et al.  Cytochrome P-450 3A4: regulation and role in drug metabolism. , 1999, Annual review of pharmacology and toxicology.

[14]  K. Tsuneyama,et al.  Involvement of Th2 cytokines in the mouse model of flutamide‐induced acute liver injury , 2012, Journal of applied toxicology : JAT.

[15]  C. Stephens,et al.  Mechanisms of drug-induced liver injury , 2014, Current opinion in allergy and clinical immunology.

[16]  K. Tsuneyama,et al.  Interleukin-17 is involved in alpha-naphthylisothiocyanate-induced liver injury in mice. , 2010, Toxicology.

[17]  P. Bernardi,et al.  High concordance of drug-induced human hepatotoxicity with in vitro cytotoxicity measured in a novel cell-based model using high content screening , 2006, Archives of Toxicology.

[18]  H. Sakaguchi,et al.  Evaluation of the skin sensitization potential of chemicals using expression of co-stimulatory molecules, CD54 and CD86, on the naive THP-1 cell line. , 2003, Toxicology in vitro : an international journal published in association with BIBRA.

[19]  M. Ingelman-Sundberg,et al.  Pro-inflammatory response and adverse drug reactions: mechanisms of action of ximelagatran on chemokine and cytokine activation in a monocyte in vitro model. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[20]  Randy M. Perse,et al.  Histopathologic analysis of suspected amiodarone hepatotoxicity. , 1990, Human pathology.

[21]  H. Hosomi,et al.  Development of a Highly Sensitive Cytotoxicity Assay System for CYP3A4-Mediated Metabolic Activation , 2011, Drug Metabolism and Disposition.

[22]  Y. Futamura.  Effect of amiodarone on cytokine release and on enzyme activities of mouse alveolar macrophages, bone marrow macrophages, and blood monocytes. , 1996, The Journal of toxicological sciences.

[23]  M. Haftek,et al.  Characterization of early events involved in human dendritic cell maturation induced by sensitizers: cross talk between MAPK signalling pathways. , 2008, Toxicology and applied pharmacology.

[24]  M. Manns,et al.  I. TNF-induced liver injury. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[25]  D. Adams,et al.  Mechanisms of immune-mediated liver injury. , 2010, Toxicological Sciences.

[26]  K. Tsuneyama,et al.  Mechanism of exacerbative effect of progesterone on drug-induced liver injury. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[27]  D. Gottschall,et al.  The metabolism of benzimidazole anthelmintics. , 1990, Parasitology today.

[28]  D. Wegmann,et al.  Role of neutrophils in a mouse model of halothane‐induced liver injury , 2006, Hepatology.

[29]  M. Raffeld,et al.  Neutrophil recruitment by intradermally injected neutrophil attractant/activation protein-1. , 1991, The Journal of investigative dermatology.

[30]  G. Tognoni,et al.  Clinical Pharmacokinetics of Amiodarone , 1984, Clinical pharmacokinetics.

[31]  E. Corsini,et al.  Role of p38 MAPK in the selective release of IL-8 induced by chemical allergen in naive THp-1 cells. , 2008, Toxicology in vitro : an international journal published in association with BIBRA.

[32]  K. Tsuneyama,et al.  Estradiol and progesterone modulate halothane-induced liver injury in mice. , 2011, Toxicology letters.

[33]  F. Follath,et al.  Identification and quantitation of novel metabolites of amiodarone in plasma of treated patients. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[34]  M. Lalloz,et al.  Binding of amiodarone by serum proteins and the effects of drugs, hormones and other interacting ligands , 1984, The Journal of pharmacy and pharmacology.

[35]  W. M. Lee,et al.  Drug-induced hepatotoxicity. , 1995, The New England journal of medicine.

[36]  Hitoshi Sakaguchi,et al.  Phenotypic alterations and cytokine production in THP-1 cells in response to allergens. , 2007, Toxicology in vitro : an international journal published in association with BIBRA.

[37]  G. Kokwaro,et al.  Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes. , 2000, British journal of clinical pharmacology.

[38]  P. Beaune,et al.  Interindividual variability in P450-dependent generation of neoantigens in halothane hepatitis. , 1998, Chemico-biological interactions.

[39]  H. Yamazaki,et al.  A significant role of human cytochrome P450 2C8 in amiodarone N-deethylation: an approach to predict the contribution with relative activity factor. , 2000, Drug metabolism and disposition: the biological fate of chemicals.

[40]  H. Sakaguchi,et al.  Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.

[41]  J. Bircher,et al.  Serum concentrations of amiodarone during long term therapy. Relation to dose, efficacy and toxicity , 2004, European Journal of Clinical Pharmacology.

[42]  Charlotte A. Ashby,et al.  Sulfamethoxazole and Its Metabolite Nitroso Sulfamethoxazole Stimulate Dendritic Cell Costimulatory Signaling1 , 2007, The Journal of Immunology.

[43]  F Peter Guengerich,et al.  Applying mechanisms of chemical toxicity to predict drug safety. , 2007, Chemical research in toxicology.

[44]  S. Krähenbühl,et al.  Hepatocellular Toxicity and Pharmacological Effect of Amiodarone and Amiodarone Derivatives , 2006, Journal of Pharmacology and Experimental Therapeutics.